Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

Although nearly 10% of Americans suffer from a rare disease, clinical progress in individual rare diseases is severely compromised by lack of attention and research resources compared to common diseases. It is thus imperative to investigate these diseases at their most basic level to build a foundat...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Peter A. Kropp (Autor), Rosemary Bauer (Autor), Isabella Zafra (Autor), Carina Graham (Autor), Andy Golden (Autor)
Médium: Kniha
Vydáno: The Company of Biologists, 2021-08-01T00:00:00Z.
Témata:
On-line přístup:Connect to this object online.
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

Connect to this object online.

3rd Floor Main Library

Informace o exemplářích z: 3rd Floor Main Library
Signatura: A1234.567
Jednotka 1 Dostupné